After Hours
$
1.34
Change
0.00 0.00%
Volume
Volume 5,185
May 26, 2022, 4:05 p.m.
Quotes are delayed by 20 min
Today's close
$ 1.40
$ 1.34
Change
-0.06 -4.29%
Day low
Day high
$1.33
$1.43

52 week low
52 week high
$1.29
$5.69

Market cap
$61.89M
Average volume
230,841
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-1.41
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on IFRX
-
InflaRx upgraded to strong buy from outperform at Raymond James
- Tomi Kilgore
-
InflaRx upgraded to outperform from market perform at Raymond James
- Tomi Kilgore
-
4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens
- Barron's Online
-
InflaRx downgraded to market perform at BMO Capital
- Tomi Kilgore
-
InflaRx downgraded to hold from buy at SunTrust RH
- Tomi Kilgore
-
InflaRx stock price target cut to $5 from $55 at SunTrust RH
- Tomi Kilgore
-
InflaRx downgraded to market perform from outperform at Raymond James
- Tomi Kilgore
-
InflaRx stock price target cut to $4 from $67 at SVB Leerink
- Tomi Kilgore
-
InflaRx downgraded to market perform from outperform at SVB Leerink
- Tomi Kilgore
-
Cronos Group and Campbell Soup Stock Rise as the Dow Pops Again
- Barron's Online
-
InflaRx stock tumbles 82% after reporting disappointing trial results
- Ciara Linnane
-
InflaRx stock price target raised to $67 vs. $65 at JPMorgan
- Ciara Linnane
-
InflaRx price target raised to $44 vs. $42 at Raymond James
- Ciara Linnane
-
InflaRx stock price target raised to $67 from $42 at SVB Leerink
- Tomi Kilgore
-
InflaRx stock price target raised to $65 from $42 at J.P. Morgan
- Tomi Kilgore
-
Samsung Warns on Revenue, but Trade Hopes Lift Global Stocks
- Barron's Online
-
InflaRx started at buy with $55 stock price target at SunTrust RH
- Tomi Kilgore
-
InflaRx started at overweight with $30 stock price target at J.P. Morgan
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For December 4, 2017
- Benzinga.com
Other News on IFRX
-
IQ, FUTU and VYNT among pre market losers
- Seeking Alpha
-
GTE, EIGR and AQST among pre market gainers
- Seeking Alpha
-
Inflarx (IFRX) Investor Presentation - Slideshow
- Seeking Alpha
-
- Seeking Alpha
-
TDOC, VXRT and CDOX among pre market gainers
- Seeking Alpha
-
TRIT and SYTA among mid-day movers
- Seeking Alpha
-
HIVE, HUT and DWAC among pre market gainers
- Seeking Alpha
-
DGLY, PHUN and BPTH among pre market gainers
- Seeking Alpha
-
AG, FRO and WATT among pre market gainers
- Seeking Alpha
-
RRD, ATNX and NXTP among premarket gainers
- Seeking Alpha
- Loading more headlines...
Press Releases on IFRX
-
InflaRx Reports Full Year 2021 Financial and Operating Results
- GlobeNewswire
-
InflaRx Announces New Pipeline Program - Oral C5aR Inhibitor
- GlobeNewswire
-
InflaRx Reports Third Quarter 2021 Financial & Operating Results
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com